Contact us

Sulfiscon awarded Innosuisse financing for its breakthrough treatment of osteoarthrisis

PACTT is proud to announce that Sulfiscon SA, a CHUV’s spin-off, led by the Dr. Alexander So, has received an Innosuisse financing to further the development of its innovative technology for the treatment of osteoarthritis, the most common degenerative disorder of the joints that affects more than half the elderly population worldwide. The project will […]

PACTT is proud to announce that Sulfiscon SA, a CHUV’s spin-off, led by the Dr. Alexander So, has received an Innosuisse financing to further the development of its innovative technology for the treatment of osteoarthritis, the most common degenerative disorder of the joints that affects more than half the elderly population worldwide. The project will be conducted in conjunction with Dr. Rainer Riedl from the Zurich University of Applied Sciences (ZHAW) and Dr. Sonia Nasi from the CHUV.

Dr. So and its Sulfiscon’s team were previously awarded in fall 2014 a FIT InnoTREK PACTT grant so as to complete an initial development phase of their technology tackling the root cause of osteoarthritis, a revolutionary approach to treat rather than only alleviate the pain as it is the case still today.

 

Table of Contents

Interested in this project? Let’s Talk

Get in touch to discuss licensing opportunities, collaborative research, or technical specifications.

Contact Us

Other news & events

All news
Uncategorized
InnoTREK: one-year financial support to create your start-up

You are a UNIL-CHUV researcher who would like to create a start-up and need a financial support to start? Apply for a one-year InnoTREK grant of CHF 100’000.- to launch your project! Applications for the InnoTREK grant can be submitted throughout the year to the Knowledge Transfer UNIL CHUV. Project selection will take place in […]

Uncategorized
BioInnovation Day 2026 : Journée dédiée aux Innovateurs & Investisseurs

  Le BIND BioInnovation Day 2026 aura lieu le 1er avril 2026 au CHUV – Auditoire César Roux. Une trentaine de projets innovants issus des meilleures institutions académiques et de recherche de Suisse occidentale y seront présentés devant le public et les investisseurs. L’événement est organisé par BioAlps en partenariat avec KT UNIL–CHUV et UNITEC. […]

Uncategorized
A Unil Discovery for Vaccine Development Turns into a Start-Up

The CRISPRi-seq technology, stemming from fundamental research within the team of Professor Jan-Willem Veening at the University of Lausanne, has reached a decisive milestone: it has been licensed to the start-up “i-Seq Biotechnology”. This innovation paves the way for new vaccines against diseases for which there is currently no protection. It all started with a […]

What is your situation ?

Our team is available to discuss your needs, for free.

For Researcher

A personalized service to inventors
In collaboration with a professional network, with regards to all aspects of technology evaluation, protection of intellectual property rights and creation of a start-up.
Learn more

For Industry

Find a collaboration, or invest in a technology
We are the primary contact point to engage in any collaboration, partnership or venture with researchers from the University of Lausanne or the CHUV.
Learn more